Key facts
- This page summarizes Kathleen D. Scott's Form 4 filing for Dermata Therapeutics, Inc. (DRMA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Jun 2026, 16:15.
Kathleen D. Scott - 16 Jun 2026 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)
- Reporting relationship
- Director
- Issuer ticker
- DRMA
- Reported as of
- 16 Jun 2026
- Net transaction value
- -$13.09
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2026, 16:15:22 UTC
- Prior SEC filing
- 05 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gerald T. Proehl, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kathleen D. Scott filed Form 4 for Dermata Therapeutics, Inc. (DRMA) on 16 Jun 2026.
Change
- Previous filing in this sequence was filed on 05 Jan 2026.
- Current net transaction value: -$13.09.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001794284
Primary reporting owner
Scott Kathleen D.
- Relationship
- Director
- Address
- 3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
- Signature
- /s/ Gerald T. Proehl, Attorney-in-Fact
- Signature date
- 16 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DRMA
transaction
Common Stock
Sale
- Transaction value
- $13.09
- Shares
- -11
- Change %
- -100%
- Price
- $1.19
- Shares after
- 0
- Date
- 16 Jun 2026
- Ownership
- Direct
DRMA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1
- Date
- 16 Jun 2026
- Ownership
- By Scott 2008 Trust Dated 3/28/08
* marks a reported price that did not pass the local price check.